Sci Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
May 08, 2020 at 02:26 am IST
Share
SCI Pharmtech, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 784.328 million compared to TWD 603.687 million a year ago. Operating income was TWD 280.202 million compared to TWD 193.768 million a year ago. Net income was TWD 208.331 million compared to TWD 164.046 million a year ago. Basic earnings per share was TWD 2.62 compared to TWD 2.06 a year ago. Diluted earnings per share was TWD 2.6 compared to TWD 2.05 a year ago.
SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical Ingredients (APIs). The Company's main products include APIs, API intermediates and special and precision chemicals. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
SCI PHARMTECH, INC. 
